Alzheimer's drug Dimebon helps Huntington's: study

WASHINGTON (Reuters) - Dimebon, a pill being developed for Alzheimer's disease, helped people with Huntington's disease improve their thinking, learning and... More

Reuters ( 2/8/2010 2:37:07 PM -08:00 )

Experimental drug shows some benefit for Huntington's disease

An experimental drug call latrepirdine has produced a small improvement in the mental abilities of some patients with Huntington's disease, a finding that... More

Los Angeles Times (blog) ( 2/8/2010 2:36:14 PM -08:00 )

Pfizer, Medivation Drug May Help Huntington's Disease Patients

Feb. 8 (Bloomberg) -- A 27-year-old hay fever treatment being studied by Pfizer Inc. and Medivation Inc. for Alzheimer's disease may... More

BusinessWeek ( 2/8/2010 1:11:58 PM -08:00 )

INTERVIEW-UPDATE 1-Medivation mulls test of Dimebon-like drugs

NEW YORK, Feb 8 (Reuters) - The chief executive officer of Medivation Inc said on Monday the company plans relatively soon to test... More

Forex Pros ( 2/8/2010 3:10:04 PM -08:00 )

Medication appears well-tolerated, beneficial in Huntington's disease patients

A medication previously studied in patients with Alzheimer's disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory... More

EurekAlert (press release) ( 2/8/2010 1:17:48 PM -08:00 )

This Month in Archives of Neurology

Testai and Gorelick (SEE ARTICLE) discuss in Part 2 homocystinuria, organic acidurias, and urea cycle disorders as metabolic disorders causal of stroke.... More

Archives of Neurology ( 2/8/2010 1:01:06 PM -08:00 )

Drug shows promise for Huntington's disease

An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve... More

PhysOrg.com ( 2/8/2010 1:00:36 PM -08:00 )

Huntington Drug Produces Slight Benefit

Explain to interested patients that latrepirdine, formerly known as dimebolin, is not FDA-approved for any... More

MedPage Today ( 2/8/2010 1:00:13 PM -08:00 )